Neuraxis, Inc. Form 8-K Summary
Business Context and Reporting Period
Neuraxis, Inc. (NRXS), a Delaware corporation listed on NYSE American, filed this Current Report on Form 8-K on May 20, 2025. The filing details a material definitive agreement entered into on the same date regarding a private placement of common stock.
Key Financial Metrics and Transaction Details
- Transaction Type: Securities Purchase Agreement for the sale of common stock.
- Shares Issued: 1,538,461 shares of Common Stock ($0.001 par value).
- Purchase Price: $3.25 per share.
- Gross Proceeds: Approximately $5.0 million (prior to fees and expenses).
- Use of Proceeds: Working capital and general corporate purposes.
- Placement Agent: Craig-Hallum Capital Group LLC (exclusive).
- Expected Closing Date: On or about May 22, 2025.
The filing does not provide specific data on revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period, as this is a transaction-specific filing rather than a periodic financial report.
Material Changes and Outlook
The primary material change is the dilution of existing shareholders due to the issuance of new shares and the anticipated increase in cash liquidity upon closing. The Company intends to utilize the net proceeds to support working capital needs. No specific forward-looking guidance regarding revenue or earnings was included in this filing.
Risks and Contingencies
The filing notes that the closing is subject to the satisfaction of customary closing conditions. It further clarifies that representations and warranties in the Purchase Agreement are for the benefit of the parties to the agreement and may apply different materiality standards than those viewed by stockholders. Information regarding these representations may change after the agreement date.
Investor Verification Checklist
- Verify the final closing date and confirmation of the $5.0 million gross proceeds.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and conditions.
- Monitor the press release (Exhibit 99.1) for any updates on the pricing or investor composition.
- Assess the impact of the 1,538,461 new shares on existing shareholder ownership percentages.